Clinical significance of pepsinogen C tumor expression in patients with stage D2 prostate carcinoma. 2002

M Díaz, and J C Rodríguez, and J Sánchez, and M T Sánchez, and A Martín, and A M Merino, and F Vizoso
Department of Urology, Hospital de Jove, Gijón, Spain.

Pepsinogen C is an aspartyl protease mainly involved in the digestion of proteins in the stomach, and an androgen-inducible protein in breast cancer cells. The aims of this study were to evaluate the expression and clinical significance of this enzyme in the primary tumors of prostate cancer patients with bone metastasis who were scheduled to receive antiandrogenic therapy. This study was prospectively performed in 28 stage D2 prostate cancer patients who, after diagnosis, received maximum androgen blockade. Pepsinogen C tumor expression was analyzed in samples (24 from needle biopsy cylinders and four from transurethral resection specimens) from primary tumors using an immunohistochemical assay. Twelve prostate carcinomas (42.8%) were positive for pepsinogen C. Pepsinogen C was a significant prognostic factor to predict a longer overall survival in the patients of our study (p<0.01). Pepsinogen C can be a new prognostic factor and a useful biological marker of androgen dependency in prostate cancer.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D009376 Neoplasms, Hormone-Dependent Certain tumors that 1, arise in organs that are normally dependent on specific hormones and 2, are stimulated or caused to regress by manipulation of the endocrine environment. Hormone-Dependent Neoplasms,Hormone Dependent Neoplasms,Hormone-Dependent Neoplasm,Neoplasm, Hormone-Dependent,Neoplasms, Hormone Dependent
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

M Díaz, and J C Rodríguez, and J Sánchez, and M T Sánchez, and A Martín, and A M Merino, and F Vizoso
January 2002, Prostate cancer and prostatic diseases,
M Díaz, and J C Rodríguez, and J Sánchez, and M T Sánchez, and A Martín, and A M Merino, and F Vizoso
August 2000, Annals of surgical oncology,
M Díaz, and J C Rodríguez, and J Sánchez, and M T Sánchez, and A Martín, and A M Merino, and F Vizoso
January 2004, The International journal of biological markers,
M Díaz, and J C Rodríguez, and J Sánchez, and M T Sánchez, and A Martín, and A M Merino, and F Vizoso
January 2004, The International journal of biological markers,
M Díaz, and J C Rodríguez, and J Sánchez, and M T Sánchez, and A Martín, and A M Merino, and F Vizoso
January 2001, The International journal of biological markers,
M Díaz, and J C Rodríguez, and J Sánchez, and M T Sánchez, and A Martín, and A M Merino, and F Vizoso
August 2002, European journal of obstetrics, gynecology, and reproductive biology,
M Díaz, and J C Rodríguez, and J Sánchez, and M T Sánchez, and A Martín, and A M Merino, and F Vizoso
July 1996, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
M Díaz, and J C Rodríguez, and J Sánchez, and M T Sánchez, and A Martín, and A M Merino, and F Vizoso
July 2015, Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery,
M Díaz, and J C Rodríguez, and J Sánchez, and M T Sánchez, and A Martín, and A M Merino, and F Vizoso
January 1983, The Prostate,
M Díaz, and J C Rodríguez, and J Sánchez, and M T Sánchez, and A Martín, and A M Merino, and F Vizoso
January 1995, The Prostate,
Copied contents to your clipboard!